Results for canakinumab
SPCs based on a second marketing authorisation - the fight continues (Novartis C-354/19) SPCs based on a second marketing authorisation - the fight continues (Novartis C-354/19) Reviewed by Dr Rose Hughes on Friday, June 28, 2019 Rating: 5
Powered by Blogger.